Drug Discovery & Development |
AstraZeneca Diabetes Treatment Looks Promising
Drug Discovery & Development AstraZeneca announced results from a Phase 3 study evaluating the investigational combination of saxagliptin/dapagliflozin as a dual add-on therapy in adult patients with type 2 diabetes who were inadequately controlled on metformin. Results from the … AstraZeneca Has Positive Results In Diabetes Trial Amid Pfizer BattleLondon South East AZ confirms positive results for diabetes drugStock Market Wire all 6 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.